EUVIMEDEUVIMED entdecken
Crossref

Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy

Bentong Yu, Mingshan Liu, Lei Jiang, Chuan Xu, Huoli Hu, Tong Huang, Dunwu Xu, Ning Wang, Qianying Li, Ben Zhong Tang iD, Xiaolin Huang, Wan Zhang

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Bentong Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Doxorubicin, Reactive Oxygen Species. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, First Affiliated Hospital of Nanchang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) with aggregation‐induced emission (AIE) photosensitizers (PSs) is a promising therapeutic strategy to achieve better anticancer results. However, eradicating solid tumors completely by PDT alone can be difficult owing to the inherent drawbacks of this treatment, and the combination of PDT with other therapeutic modalities provides opportunities to achieve cooperative enhancement interactions among various treatments. Herein, this work presents the construction of a biocompatible nanocomposite, namely CaO 2 @DOX@ZIF@ASQ, featuring light‐responsive reactive oxygen species (ROS) generation and tumor‐targeting oxygen and hydrogen peroxide discharge, as well as controlled doxorubicin (DOX) and copper ion release, thus allowing the combined PDT/CT/CDT effect by AIE PS‐enhanced PDT, DOX‐based chemotherapy (CT), and copper‐involved Fenton‐like reaction‐driven chemodynamic therapy (CDT). In vitro and in vivo studies verify that the generation of both ROS and O 2 by this nanomedicine, stimulated by light, exhibits superior anticancer efficacy, alleviating tumor hypoxia and achieving synergistic PDT/CT/CDT therapeutic effect. This multifunctional nanomedicine remarkably suppresses the tumor growth with minimized systemic toxicity, providing a new strategy for constructing multimodal PDT/CT/CDT therapeutic systems to overcome hypoxia limitations, and potentially increase the antitumor efficacy at lower doses of PSs and chemotherapeutic drugs, thus minimizing potential toxicity to non‐malignant tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsDoxorubicinReactive Oxygen SpeciesNanomedicineAnimalsHumansMiceCell Line, TumorNeoplasmsAntineoplastic AgentsMice, Inbred BALB CFemaleCopperMice, Nude

Stichwörter der Autor:innen

aggregation‐induced emission photosensitizerscalcium peroxidechemodynamic therapychemotherapyphotodynamic therapysynergistic therapyzeolitic imidazolate framework

Substanzen

Photosensitizing AgentsDoxorubicinReactive Oxygen SpeciesAntineoplastic AgentsCopper

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
  • Jiangxi Hospital of China-Japan Friendship Hospital, National Regional Center for Respiratory Medicine Nanchang, Nanchang, Jiangxi, 330000, P. R. China.
  • Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330000, P. R. China.
  • Department of Cardiothoracic Surgery, Zhongshan People's Hospital, Zhongshan, Guangdong, 528499, P. R. China.
  • State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Nanchang University, Nanchang, 330047, P. R. China.
  • School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, P. R. China.

ORCID-Profile: Ben Zhong Tang

Förderung

  • National Natural Science Foundation of China
  • Jiangxi Provincial Natural Science Foundation
  • First Affiliated Hospital of Nanchang University
  • Shenzhen Key Laboratory of Functional Aggregate Materials
  • Science Technology Innovation Commission of Shenzhen Municipality

Zitieren

APA

Yu, B., Liu, M., Jiang, L., Xu, C., Hu, H., Huang, T., Xu, D., Wang, N., Li, Q., Tang, B. Z., Huang, X., & Zhang, W. (2024). Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303643

Vancouver

Yu B, Liu M, Jiang L, Xu C, Hu H, Huang T, et al. Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303643

BibTeX
@article{Yu2024,
  author = {Yu, Bentong and Liu, Mingshan and Jiang, Lei and Xu, Chuan and Hu, Huoli and Huang, Tong and Xu, Dunwu and Wang, Ning and Li, Qianying and Tang, Ben Zhong and Huang, Xiaolin and Zhang, Wan},
  title = {Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303643}
}
Kostenlos starten →